MAIA Biotechnology Reports Full Year 2022 Financial Results and Provides Corporate Update
Patient enrollment underway in Europe in ongoing Phase 2 trial in NSCLC (THIO-101) Outlined plan to initiate second Phase 2…
Pharmaceuticals, Biotechnology and Life Sciences
Patient enrollment underway in Europe in ongoing Phase 2 trial in NSCLC (THIO-101) Outlined plan to initiate second Phase 2…
LOS GATOS, Calif. & SAN FRANCISCO–(BUSINESS WIRE)–#AcceleratedSalesExecution–The Sales Ops Group, the sales strategy and transformation consulting company that accelerates the…
QUEBEC CITY–(BUSINESS WIRE)–Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXv: GSD; OTCQB: DVHGF), a clinical stage botanical pharmaceutical corporation,…
Financing focused on domestic biomanufacturing capacity and capabilities for biologics, vaccines, and nucleic acids SAN DIEGO–(BUSINESS WIRE)–#biomanufacturing–National Resilience, Inc. (Resilience),…
SAN DIEGO–(BUSINESS WIRE)–Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, announces enrollment of the…
DUBLIN–(BUSINESS WIRE)–The “Global Markets for Bioengineered Protein Drugs” report has been added to ResearchAndMarkets.com’s offering. The global bioengineered protein drugs…
NEW HAVEN, Conn., March 23, 2023 (GLOBE NEWSWIRE) — BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI) (the “Company” or “Bioasis”), a multi-asset…
Starting in 2023, Celyad Oncology is now entirely focused on its new business strategy with one clear objective: help to…
Call/webcast to feature updates on the discovery platform and pipeline, including updated data from the ongoing Phase 1b trial of…
Daix (France), Long Island City (New York, United States), March 23, 2023 – Inventiva (Euronext Paris and Nasdaq: IVA) (the…